Aspira Women's Health

Aspira Women’s Health, Inc. is transforming women’s health, dedicated to improving the lives of women - starting with Ovarian Cancer. The combination of OVA1plus and genetic testing for hereditary cancer syndromes helps providers understand a patient’s true risk for cancer to inform medical management. We are devoted to combatting racial disparities that currently exist in ovarian cancer risk assessment. For women with adnexal masses - OVA1plus is the best test for detecting Ovarian Cancer Risk. NPV of 98%, Sensitivity of 96%, Outperforms CA125:, Detecting Early-Stage Disease, Detecting risk in Pre-menopausal Women, Sensitivity in African American Women, FDA-Cleare, Aspira GenetiX offers Targeted Gynecologic and Comprehensive Gynecologic Panels to understand Hereditary Genetic Risk. Visit our website at www.aspirawh.com.... More Info Less Info